Eurospital S.p.A.

What Eurospital S.p.A. does

Eurospital S.p.A. is an Italian pharmaceutical, in-vitro diagnostic, and special nutrition company headquartered in Trieste and founded in 1948 by Giorgio Kropf. The company operates across three integrated business areas — Diagnostics, Pharmaceuticals, and Special Nutrition — producing ethical and over-the-counter drugs, medical devices, in-vitro diagnostic kits and instruments, gluten-free and low-protein foods, and food supplements. The Diagnostics portfolio spans celiac disease (α-Gliatest IgA/G, Eu-tTG IgA, XeliGen), gastroenterology (Calprest, Calprest Turbo NG, EasyCal, Eu-Turbo Analyzer, Eu-Fast Reader), and molecular biology / genetic testing (DiabeGen, LactoGen, Eu-Gen MTHFR Dual-Type, Eu-Gen FII/FV Type) built on Real Time PCR, turbidimetric analysis, immunochromatographic, and multiplexing platforms. The Pharmaceutical portfolio includes proprietary brands such as Haliborange, Dequadin, Sterilens, Pasta Eurospital, Non Ad Garze, Fiordinaso, Enemac, Torch, Anberries, the Personal Care line, and market-leading infusion solutions. Special Nutrition spans the Piaceri Mediterranei gluten-free line (150+ products) and the Apromé low-protein line (launched mid-2024) for patients with celiac disease, chronic kidney disease, phenylketonuria, and Parkinson's disease.

The company makes money predominantly through one-time sales of pharmaceutical products, in-vitro diagnostic kits and instruments, medical devices, and special nutrition foods across more than 50 countries. In Italy it operates a direct sales force targeting pharmacies and parapharmacies; internationally it distributes through partnerships covering South America, the Middle East, and Southeast Asia, and additionally earns fee income from exclusive distribution of third-party brands (Waterdrop, Lactosolution, Glassio). Customer segments include Italian pharmacies/parapharmacies as the primary B2B channel, hospitals and diagnostic laboratories for IVD kits and instruments, and end consumers with dietary restrictions. Pricing is not publicly disclosed. FY2025 revenue reached €43.5 million with double-digit growth versus FY2024 (€38.5M), driven by all three divisions — Special Nutrition is explicitly the fastest-growing area. Eurospital is a family-controlled private company (S.p.A.) currently in its third generation of Kropf-family leadership, with approximately 180 employees, regulatory certifications including IVDR (first Italian company, 2022), FDA approval for the calprotectin test, MDSAP, ISO 9001:2015, and ISO 13485:2016, and R&D intensity of 7% of Diagnostics revenue directed at 15 active research projects with ~10% of workforce.

Name

Eurospital S.p.A.

Legal name

Eurospital S.p.A.

Website

https://eurospital.com

Company type

Private

Founded year

1948

Operating status

Operating

Headcount range

51–100 employees

Short description

Eurospital S.p.A. is an Italian pharmaceutical and in-vitro diagnostic company that develops and markets drugs, medical devices, IVD kits and instruments, and special nutrition products across Diagnostics, Pharmaceuticals, and Special Nutrition divisions, serving pharmacies, hospitals, and patients in over 50 countries.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• In vitro diagnostics
• Pharmaceutical manufacturing
• Medical devices
• Special nutrition foods
• Molecular diagnostics

Headquarters

HQ city

Trieste

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Products: Sale of prescription (ethical) and over-the-counter drugs, including branded products such as Haliborange, Dequadin, Sterilens, Pasta Eurospital, Non Ad Garze, Enemac, Torch, and the Personal Care line. Includes infusion solutions where Eurospital holds a market leadership position.
2. In Vitro Diagnostics: Sale of diagnostic tests, instruments, and kits for celiac disease, gastroenterology, molecular biology, autoimmunity, infectious diseases, and genetic testing. Includes the Eu-Turbo Analyzer, Calprest, and genetic test kits sold to hospitals, laboratories, and pharmacies.
3. Special Nutrition Products: Sale of gluten-free foods (Piaceri Mediterranei line) and low-protein foods (Apromé line) distributed in pharmacies and specialized retail outlets. The Special Nutrition area encompasses over 150 products and is the fastest-growing business area.
4. Medical Devices: Sale of medical devices including infusion sets, nasal care devices (Fiordinaso), wound care products (Non Ad Garze), eye care products (Sterilens), and diagnostic instruments. Distributed through pharmacy and hospital channels.
5. Third-Party Brand Distribution: Exclusive distribution partnerships for complementary brands in the Italian pharmacy channel, including Waterdrop microdrinks, Lactosolution lactose intolerance supplement, and Glassio reading glasses, generating additional revenue streams.
6. Cosmetics and Food Supplements: Sale of cosmetic products and food supplements including Haliborange vitamin D supplements, distributed through pharmacy and parapharmacy channels.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Eurospital S.p.A. produces and commercializes pharmaceutical products (prescription and OTC drugs, infusion solutions), medical devices (sterile dressings, nasal nebulizers, contact lens care), in-vitro diagnostic kits and instruments (for celiac disease, gastroenterology, molecular biology, autoimmunity, infectious diseases, and genetic testing), special nutrition foods (gluten-free and low-protein), and food supplements (vitamins). It sells through a direct sales force to Italian pharmacies and parapharmacies, international distribution partners, and specialized retail outlets in over 50 countries.

Product overview

Eurospital S.p.A. is an Italian pharmaceutical company with over 75 years of history, operating across three distinct business areas: Diagnostic Area, Pharmaceutical Area, and Special Nutrition Area. The Diagnostic Area encompasses products for celiac disease (α-Gliatest, XeliGen genetic tests), gastroenterology (Calprest, Calprest Turbo NG, EasyCal, Eu-Turbo Analyzer, Eu-Fast Reader for fecal calprotectin testing), molecular biology (DiabeGen, LactoGen, Eu-Gen FII/FV Type, Eu-Gen MTHFR Dual-Type using Real Time PCR technology with Multiplexing Technology), autoimmunity, infectious diseases, and genetic testing. The Pharmaceutical Area includes prescription and OTC drugs (Eurospital Solutions, infusion sets with Euroset), medical devices (Non Ad Garze, sterile syringes), eye care (Sterilens One Plus, Sterilens Idra), nasal care (Fiordinaso), wound care, skin care products (Pasta Eurospital, Crema Riparatrice), oral care (Dequadin), supplements (Haliborange vitamins), constipation treatments (Enemac, Glycerol), licorice products (Torch), throat pastilles (Anberries), and the Personal Care line launched in 2023. The Special Nutrition Area focuses on gluten-free products through Piaceri Mediterranei brand and low-protein foods through Apromé brand, with over 150 products distributed in pharmacies and specialized outlets.

Differentiator

Problem solved

Functional benefit

Brands

• Piaceri Mediterranei: Gluten-free food product line for individuals with celiac disease or gluten intolerance
• Apromé
• Haliborange
• Dequadin
• Sterilens
• Torch
• Non Ad Garze
• Pasta Eurospital
• Fiordinaso
• Anberries
• Enemac
• Personal Care
• XeliGen
• DiabeGen
• LactoGen
• Eu-Gen FII/FV Type
• Eu-Gen MTHFR Dual-Type
• Eu-Turbo Analyzer
• Eu-Fast Reader
• Calprest Turbo NG

Products and services

• Piaceri Mediterranei Gluten-free food product line combining Italian food tradition with diagnostic expertise. Includes pasta, snacks, baked goods, and the Piacerini sweet snack line, all certified gluten-free. Sold in pharmacies and specialized retail outlets in Italy, Spain, Germany, Canada, and expanding in North America, targeting consumers with celiac disease or gluten intolerance.
• Apromé Low-protein food product line for individuals following diets reduced in protein, sodium, phosphorus, potassium, and phenylalanine. Targeted at patients with Chronic Kidney Disease (CKD), Phenylketonuria (PKU), and Parkinson's Disease undergoing levodopa therapy. Distributed through pharmacies and specialized retail outlets.
• Haliborange

Quantifiable outcome

• First non-invasive in vitro test worldwide for celiac disease detection (α-Gliatest IgA, launched 1988), developed with Burlo Garofolo Hospital and Universities of Naples and Trieste
• +4 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

Feature9 records

Partnerships

Seven partnerships are on record, tiered minor and core.

• MATTADOR Cultural AssociationminorGTM or Marketing Partner · 1 July 2024Eurospital partnered with the MATTADOR Cultural Association (based in Trieste) to support young people in cinema, as part of the company's cultural and social responsibility initiatives. The partnership supports the MATTADOR Award dedicated to young filmmakers.
• ITS FoundationminorGTM or Marketing Partner · 4 April 2024Eurospital sponsors the ITS Foundation and participates in the ITS Contest 2023/2024 'Born to Create' with the Anberries candy brand, supporting creativity and sustainability among students.
• GlassiominorChannel Partner/ Reseller/ Distributor · 1 January 2024In 2024, Eurospital began distributing Glassio reading glasses through a new commercial partnership, expanding its product portfolio in the pharmacy channel.
• LactosolutionminorChannel Partner/ Reseller/ Distributor · 22 September 2023Eurospital became the exclusive distributor for the Lactosolution 15,000 food supplement for lactose intolerance in the pharmacy and specialized store channel in Italy. The product registered significant growth in performance during 2025.
• WaterdropminorChannel Partner/ Reseller/ Distributor · 10 May 2023Eurospital was appointed as the exclusive distributor of Waterdrop microdrinks in Italian pharmacies and specialized stores starting May 2023. Waterdrop is a successful Austrian startup (founded 2016) with annual revenue exceeding €90 million in 2021. The partnership was presented at a joint event in Bologna on May 10, 2023, and reflects shared values of innovation and quality.
• Di Renzo S.r.l.minorImplementation/ SI/ Consulting PartnerDi Renzo S.r.l. serves as the external data processor for pharmacovigilance activities on behalf of Eurospital. Based in Rome (operational headquarters at Via dell'Arco di Travertino 11, 00178 Roma), the company handles adverse reaction reports and pharmacovigilance compliance under EU Regulation 679/2016.
• Burlo Garofolo HospitalcoreStrategic or Co-development PartnerCollaboration with IRCCS Burlo Garofolo (Trieste) in partnership with the Universities of Naples and Trieste led to the development and launch of α-Gliatest IgA in 1988 — the first non-invasive in vitro test worldwide for celiac disease. This collaboration established Eurospital as a leader in celiac diagnostics.

Scale indicators11 records

Recent moves8 records

Expansion highlights7 records

Emerging players

• CerTest Biotec: Spanish specialty IVD developer focused on immunochromatographic rapid tests, real-time PCR molecular kits, and infectious-disease diagnostics. Closely comparable to Eurospital's molecular biology and gastroenterology diagnostics in product category, technology (PCR, lateral flow), and European focus.

Broad incumbents

• bioMérieux: French global IVD leader with extensive microbiology, molecular biology, and immunoassay portfolios serving hospitals and reference labs. Comparable as a broad incumbent in molecular biology and infectious-disease IVD that competes for the same hospital/laboratory accounts Eurospital targets, albeit with a much larger portfolio.
• Chiesi Farmaceutici: Italian-headquartered global pharmaceutical company with respiratory, rare-disease, and consumer-health franchises. Comparable to Eurospital's Pharmaceutical Division as an Italian pharma with ethical/OTC products distributed through pharmacy/hospital channels in Europe and internationally.
• Menarini Group: Italy's largest privately-held pharmaceutical group with OTC, consumer-health, and specialty pharma operations across 100+ countries. Comparable to Eurospital as an Italian-rooted multi-division pharma company with strong pharmacy-channel presence and international distribution.
• Angelini Industries: Italy-headquartered privately-held diversified group with pharmaceuticals (Angelini Pharma), consumer healthcare, and OTC brands. Comparable to Eurospital's pharmaceutical operations as an Italian family/group-owned company selling OTC and consumer-health brands through pharmacies domestically and internationally.

Direct peers

• DiaSorin: Italian-headquartered global IVD company listed on the Italian Stock Exchange focused on immunodiagnostics and molecular diagnostics, including gastrointestinal and infectious-disease assays. Directly comparable to Eurospital's Diagnostics Division in product category (specialty IVD), sales channels (hospital/lab), and geographic mix (strong Italian/European footprint).
• Dr. Schär: Italy-based (and family-owned) global leader in gluten-free and low-protein specialty foods for celiac, PKU, and other dietary-restriction patients. Directly comparable to Eurospital's Special Nutrition division (Piaceri Mediterranei and Apromé) in product category, regulatory positioning, and pharmacy/specialized-retail distribution.
• Bühlmann Laboratories: Swiss specialty diagnostics company whose Bühlmann Calprotectin tests and CALEX Cap fecal-calprotectin sample-prep products compete head-to-head with Calprest/Calprest Turbo NG. Closely comparable in product category (fecal calprotectin for IBD), customer base (clinical labs/hospitals), and technology (turbidimetric and lateral-flow immunoassays).
• R-Biopharm: German specialty diagnostics company with strong clinical diagnostics (including food allergens and celiac-disease screening), nutritional supplements, and analytical-test kits. Comparable to Eurospital's Diagnostics Division in celiac/gluten-related testing and to its gluten-free/Nutrition portfolio through complementary kit and food businesses.
• Alifax: Italian IVD company developing automated clinical-chemistry and hematology analyzers plus specialty diagnostic kits. Comparable to Eurospital's Diagnostics Division as an Italian-headquartered specialty IVD manufacturer selling proprietary instruments (analogy to Eu-Turbo Analyzer) plus reagents to clinical laboratories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/sharer.php?u=https://www.eurospital.com
• LinkedInlinkedin.com/company/eurospital-spa

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eurospital S.p.A.